<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE306nnn/GSE306630/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306630</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Interplay of Pro-coagulatory and Neutrophil-derived Anti-coagulatory proteins in C1q-NET driven blood coagulation</name><description>Neutrophils interact with the external milieu in both tissue and blood microenvironments and are emerging as important regulators of blood coagulation 1-3. In this study, we explored whether complement induces Neutrophil Extracellular Trap (NET) formation and related blood coagulation using human donor-derived neutrophils. Complement C1q induces NETosis in Lipopolysaccharide (LPS) O127 primed neutrophils, while LPS alone does not induce NETosis. Bulk RNA sequencing revealed a unique LPS-driven altered neutrophil state and complement sensitivity for NETosis was found to be transcriptionally- dependent. Using an arrayed CRISPR Knockout screen in the neutrophil-like differentiated HL60 cells (dHL60), we identified that SCARF1 and Complement Receptor 3 are required for C1q-NETosis. Since NETs contain pro- coagulatory components such as DNA and histones, we investigated whether C1q-related NETs influenced blood coagulation. LPS+ C1q NETs were associated with reduced coagulation activity compared to LPS treatment alone. We further found that LPS upregulated Tissue Factor expression and coagulation-related activity in neutrophils. Furthermore, neutrophils secrete anticoagulant proteins, including Protein C and Tissue Factor Pathway Inhibitors, during C1q- mediated NET formation that functionally regulates NET-related coagulation. C1q- NETs also activate the coagulation factors FXII and FXI, facilitating both intrinsic coagulation and kallikrein-dependent bradykinin production. This study elucidates how NETs regulate both pro- coagulatory and anti-coagulatory components that may influence pathophysiology of disease.</description><dates><publication>2026/08/27</publication></dates><accession>GSE306630</accession><cross_references><GSM>GSM9204933</GSM><GSM>GSM9204944</GSM><GSM>GSM9204943</GSM><GSM>GSM9204942</GSM><GSM>GSM9204952</GSM><GSM>GSM9204941</GSM><GSM>GSM9204937</GSM><GSM>GSM9204948</GSM><GSM>GSM9204947</GSM><GSM>GSM9204936</GSM><GSM>GSM9204946</GSM><GSM>GSM9204935</GSM><GSM>GSM9204934</GSM><GSM>GSM9204945</GSM><GSM>GSM9204940</GSM><GSM>GSM9204951</GSM><GSM>GSM9204950</GSM><GSM>GSM9204939</GSM><GSM>GSM9204949</GSM><GSM>GSM9204938</GSM><GPL>16791</GPL><GSE>306630</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>